Compare Edwards Lifesciences Corporation Common Stock (EW) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Heron Therapeutics Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.02 (market cap $48.56B), while Heron Therapeutics Inc trades at $0.39 (market cap $68.01M). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 714× Heron Therapeutics Inc's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| EW | HRTX | |
|---|---|---|
Market Cap | $48.56B | $68.01M |
Volume | 6,520,488 | 1,891,941 |
Sector | Health | Health |
52-Week High | $95.18 | $1.49 |
52-Week Low | $72.65 | $0.27 |
Enterprise Value | $45.01B | $174.75M |
Typical Hold Time | — | 35 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Heron Therapeutics (HRTX) trades at $0.39, up 0.95% with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings discussions.
The outlook remains challenged by persistent losses and negative margins, though strong analyst support suggests potential upside. Key risks include execution on sales targets and achieving profitability. The stock's low price near 52-week lows presents speculative opportunity but requires careful risk management given financial performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
